Accueil   Appels à projets   H2020 Health - Calls 2020 - 1.3 Infectious diseases (1 stage RIA)

H2020 Health – Calls 2020 – 1.3 Infectious diseases (1 stage RIA)

Call 1 better health care
1.3 Infectious diseases and improving global health

Les grandes lignes de l'appel à projets

Type de l'appel : Collaboratif

Date d'ouverture : 25 Juin 2019

Date de clôture : 4 Juin 2020

Dimension : Europe

Financement :

Type de financement : Subvention

Thématique(s) médicale(s) : Toutes thématiques

Secteur(s) industriel(s) :

SC1-BHC-17-2020: Global Alliance for Chronic Diseases (GACD) - Prevention and/or early diagnosis of cancer

Scope: Proposals should focus on implementation research for the prevention and/or early diagnosis of cancer on in LMIC and/or in vulnerable populations in HIC. Proposals should build on interventions with promising or proven effectiveness (including cost-effectiveness) for the respective population groups under defined contextual circumstances. For promising interventions, a limited validation period can be envisaged. However, the core of the research activities should focus on their implementation in real-life settings. The proposed interventions should gender-responsive. The aim should be to adapt and/or upscale the implementation of these intervention(s) in accessible, affordable and equitable ways in order to improve the prevention and early diagnosis of cancer in real-life settings. Interventions should meet conditions and requirements of the local health and social system context and address any other contextual factors identified as possible barriers.

SC1-BHC-33-2020: Addressing low vaccine uptake

Scope: Proposals should work to increase understanding of the determinants of low vaccine uptake in specific contexts situated in the EU and/or Associated Countries (AC) , and should develop strategies to increase vaccination rates of essential vaccines within these contexts. From this work, proposals should aim to develop a series of recommendations that national and regional public health authorities in the EU and/or Associated Countries could implement in order to increase vaccine coverage. Proposals should build on existing research, findings and available information in this domain, as well as existing guidelines and recommendations from public health authorities, including those from the European Centre for Disease Prevention and Control and WHO/Europe (such as ECDC reports and guidance on vaccine coverage and hesitancy , “WHO/SAGE Working Group on Vaccine Hesitancy” , WHO/Europe “Guide to tailoring immunization programmes (TIP)”…

SC1-BHC-34-2020: New approaches for clinical management and prevention of resistant bacterial infections in high prevalence settings

Scope: Proposals should focus on the identification of best practices, and the development and validation of interventions, infection prevention and clinical management plans for dealing with resistant bacterial infections in high prevalence settings. The research needs to take into account the variety and capacities of local health care/nosocomial infrastructures, and the trends of resistance patterns on local, national and international level, as well as sex and/or gender differences, when relevant. Furthermore, research needs to lead to management plans that take into account commonalities as well as differences between different pathogens and resistance determinants.

SC1-BHC-35-2020: Creation of a European wide sustainable network for harmonised large-scale clinical research studies for infectious diseases

Scope: Proposals should set up a European-wide multidisciplinary network able to provide a platform for a rapid response in the conduct of clinical studies in relation to any severe infection. The initial clinical studies to be performed should be included in the proposal, whereas criteria and processes for including further clinical studies in the project should be clearly described. This should include provisions for flexibility (including re-allocation of budget and de-prioritisation) in case of new scientific developments and in particular the need
to address newly or re-emerging infectious diseases.

En poursuivant votre navigation sur notre site, vous acceptez l'utilisation des cookies et la collecte de vos données et informations personnelles par Lyonbiopôle, dans les finalités de mesurer le trafic sur le site Web, de fournir des statistiques et de vous proposer des contenus adaptés à vos centres d’intérets. Pour exercer vos droits d'accès, de rectification, d'opposition, de suppression et de portabilité, conformément au règlement général sur la protection des données (UE n°2016/679), vous etes informés que vous pouvez envoyer votre demande à dpo@lyonbiopole.com. Plus de détails sont disponibles en cliquant ici J'accepte